Neptune Tech & Bioresource

NEPT-T

TSE:NEPT

4.06
0.18 (4.25%)
Neptune Wellness Solutions is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands.
More at Wikipedia

Analysis and Opinions about NEPT-T

Signal
Opinion
Expert
SPECULATIVE BUY
SPECULATIVE BUY
October 7, 2013

Had trouble selling fishy tasting product but have resolved that. It is a bit of a concept stock. Be careful the valuation does not get out of whack with what they are able to deliver.

Show full opinionHide full opinion

Had trouble selling fishy tasting product but have resolved that. It is a bit of a concept stock. Be careful the valuation does not get out of whack with what they are able to deliver.

TOP PICK
TOP PICK
September 4, 2013

Owns 65% of Acasti Pharma (APO-X) which is in phase 2 trials of its drug CaPre. As those things come out, this is a market that historically has been as big as $20 billion of sales when Lipitor was pre-generic. Thinks this will be a category killer and will be taken over by one of the big pharmas once they get into phase 3 trials. Also have a small base business selling products that health-food stores call Neptune Krill Oil, which produces a nice cash flow.

Show full opinionHide full opinion

Owns 65% of Acasti Pharma (APO-X) which is in phase 2 trials of its drug CaPre. As those things come out, this is a market that historically has been as big as $20 billion of sales when Lipitor was pre-generic. Thinks this will be a category killer and will be taken over by one of the big pharmas once they get into phase 3 trials. Also have a small base business selling products that health-food stores call Neptune Krill Oil, which produces a nice cash flow.

COMMENT
COMMENT
August 2, 2013

They basically take krill (small shrimp), extracts the oil from them which is then used to reduce cholesterol in a natural way. There is a potential for combining their product with conventional statins for different methodology. Analysts are expecting this company will lose $0.15 for the Feb/14 year and another $0.02 a year later. Interesting opportunity but not profitable for the foreseeable future.

Show full opinionHide full opinion

They basically take krill (small shrimp), extracts the oil from them which is then used to reduce cholesterol in a natural way. There is a potential for combining their product with conventional statins for different methodology. Analysts are expecting this company will lose $0.15 for the Feb/14 year and another $0.02 a year later. Interesting opportunity but not profitable for the foreseeable future.

STRONG BUY
STRONG BUY
May 2, 2013

(Market Call Minute.) Table pounding buy. Have phase 2 data coming in the next 6 months which will catapult the stock up multiples.

Show full opinionHide full opinion

(Market Call Minute.) Table pounding buy. Have phase 2 data coming in the next 6 months which will catapult the stock up multiples.

HOLD
HOLD
April 4, 2013

In the Pharma space. Had been a long, long time in the making, trying to get some traction in the market with revenues and partners. Last year had a giant explosion at their plant. Now they have to rebuild and get investors re-interested in the game.

Show full opinionHide full opinion

In the Pharma space. Had been a long, long time in the making, trying to get some traction in the market with revenues and partners. Last year had a giant explosion at their plant. Now they have to rebuild and get investors re-interested in the game.

DON'T BUY
DON'T BUY
January 8, 2013

This company has had all kinds of uncertainties. Would have no interest in owning this one.

Show full opinionHide full opinion

This company has had all kinds of uncertainties. Would have no interest in owning this one.

SELL
SELL
June 15, 2012
(Mark Call Minute.) Has been a concept stock for a long period of time. Had a big run here but still no earnings.
Show full opinionHide full opinion
(Mark Call Minute.) Has been a concept stock for a long period of time. Had a big run here but still no earnings.
BUY
BUY
April 18, 2012
(Market Call Minute.) Interesting. Basically have little itty-bitty shrimp to get curl oil (?) which is used to produce Omega oils for reduction of cholesterol. Speculative but they have pretty good opportunities in sales over the coming 12 months.
Show full opinionHide full opinion
(Market Call Minute.) Interesting. Basically have little itty-bitty shrimp to get curl oil (?) which is used to produce Omega oils for reduction of cholesterol. Speculative but they have pretty good opportunities in sales over the coming 12 months.
HOLD
HOLD
July 8, 2008
(Market call minute.)Likes the potential but in this environment the stock has been killed.
Show full opinionHide full opinion
(Market call minute.)Likes the potential but in this environment the stock has been killed.
STRONG BUY
STRONG BUY
April 22, 2008
Extremely excited about the opportunity for the company. Has multi-billion-dollar potential. One product is for HDL, good cholesterol. Also have a food additive business. Not widely covered.
Show full opinionHide full opinion
Extremely excited about the opportunity for the company. Has multi-billion-dollar potential. One product is for HDL, good cholesterol. Also have a food additive business. Not widely covered.
STRONG BUY
STRONG BUY
April 2, 2008
Krill oil that has a number of therapeutic benefits. Just signed an agreement for global distribution of an omega 3 product. Just got a patent on their pharmaceutical product for boosting of HDL levels.
Show full opinionHide full opinion
Krill oil that has a number of therapeutic benefits. Just signed an agreement for global distribution of an omega 3 product. Just got a patent on their pharmaceutical product for boosting of HDL levels.
PAST TOP PICK
PAST TOP PICK
March 31, 2008
(Top pick, March 26 2007. Down 45%) The companies fundamentals have done nothing but improve over last 12 months.
Show full opinionHide full opinion
(Top pick, March 26 2007. Down 45%) The companies fundamentals have done nothing but improve over last 12 months.
TOP PICK
TOP PICK
March 31, 2008
The fundamentals have improved dramatically as the stock has fallen. The product will be likely implemented within 5 years.
Show full opinionHide full opinion
The fundamentals have improved dramatically as the stock has fallen. The product will be likely implemented within 5 years.
TOP PICK
TOP PICK
March 4, 2008
Has had a bad 12 months even as the fundamentals have built strongly in the right direction. He looks at the stock as having the biggest upside in his portfolio in the next 2 to 3 years.
Show full opinionHide full opinion
Has had a bad 12 months even as the fundamentals have built strongly in the right direction. He looks at the stock as having the biggest upside in his portfolio in the next 2 to 3 years.
BUY
BUY
February 25, 2008
Fairly volatile. Basing quite nicely in the low $3's. Most exciting part is the pharmaceutical potential with their krill oil, which increases good cholesterol.
Show full opinionHide full opinion
Fairly volatile. Basing quite nicely in the low $3's. Most exciting part is the pharmaceutical potential with their krill oil, which increases good cholesterol.
Showing 31 to 45 of 65 entries